Dr. Jorg Taubel will be attending the EPI | Lifestyle Scientific Sessions 2024. Taking place from 18th to 21st March in Chicago, Illinois, this event is a cornerstone for professionals in the field of epidemiology, prevention, and lifestyle medicine, with a particular focus on cardiometabolic health.
Dr. Taubel's presence at the conference promises to enrich the discussions and debates surrounding epidemiological cardiovascular issues and the impact of lifestyle trends. We anticipate engaging sessions that delve deep into understanding and addressing the intersection of lifestyle factors and cardiovascular health.
Richmond Pharmacology highlights encouraging first-in-human results for Regeneron's investigational RNAi therapy in MASLD
November 12, 2026
NEJM publication and AASLD presentation reports that 79% of treated participants with MASLD and available measurements achieved normal liver fat levels at Week 24 after a single dose of CIDEBsiRNA, alongside improvements in markers of liver injury.
Richmond Pharmacology is excited to join the AHA Scientific Sessions 2026 in 14–16 November 2026, on 14–16 November 2026, hosted by the American Heart Association.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
